Reply to Upton et al
- 29 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 77 (1), 158-159
- https://doi.org/10.1093/cid/ciad188
Abstract
Russell R Kempker, Maia Kipiani, Charles A Peloquin; Reply to Upton, et al., Clinical Infectious Diseases, , ciad188, https://doi.org/10.1093/cid/ciad188Funding Information
- National Institutes of Health (D43 TW007124)
- National Institute of Allergy and Infectious Diseases (R03 AI139871)
This publication has 9 references indexed in Scilit:
- Cerebrospinal Fluid and Tuberculous MeningitisClinical Infectious Diseases, 2023
- Dynamic 18F-Pretomanid PET imaging in animal models of TB meningitis and human studiesNature Communications, 2022
- Long term outcomes of patients with tuberculous meningitis: The impact of drug resistancePLOS ONE, 2022
- Anti-tuberculosis treatment strategies and drug development: challenges and prioritiesNature Reviews Microbiology, 2022
- Pharmacokinetics of bedaquiline in cerebrospinal fluid (CSF) in patients with pulmonary tuberculosis (TB)Journal of Antimicrobial Chemotherapy, 2022
- Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential UsefulnessClinical Infectious Diseases, 2021
- Radiosynthesis and PET Bioimaging of 76Br-Bedaquiline in a Murine Model of TuberculosisACS Infectious Diseases, 2019
- Long-term Mortality of Patients With Tuberculous Meningitis in New York City: A Cohort StudyClinical Infectious Diseases, 2016
- Quantitation of Bedaquiline: Points of Attention: Table 1.Clinical Infectious Diseases, 2016